Correlation Between Apellis Pharmaceuticals and Avadel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apellis Pharmaceuticals and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Avadel Pharmaceuticals.

Diversification Opportunities for Apellis Pharmaceuticals and Avadel Pharmaceuticals

0.62

Correlation Coefficient

Apellis Pharmaceuticals  Avadel Pharmaceuticals

Poor diversification

The 3 months correlation between Apellis and Avadel is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Avadel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Apellis Pharmaceuticals and Avadel Pharmaceuticals

Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.24 times less return on investment than Avadel Pharmaceuticals. In addition to that, Apellis Pharmaceuticals is 1.38 times more volatile than Avadel Pharmaceuticals PLC. It trades about 0.07 of its total potential returns per unit of risk. Avadel Pharmaceuticals PLC is currently generating about 0.13 per unit of volatility. If you would invest  904.00  in Avadel Pharmaceuticals PLC on May 4, 2025 and sell it today you would earn a total of  204.00  from holding Avadel Pharmaceuticals PLC or generate 22.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Apellis Pharmaceuticals  vs.  Avadel Pharmaceuticals PLC

Apellis Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Apellis Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady essential indicators, Apellis Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Avadel Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Avadel Pharmaceuticals PLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Avadel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apellis Pharmaceuticals and Avadel Pharmaceuticals

The main advantage of trading using opposite Apellis Pharmaceuticals and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.

The idea behind Apellis Pharmaceuticals and Avadel Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.